PH 302

Known as: PH-302, PH302 cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2013
0119992013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
SUMMARY A novel hydrophilic matrix tablet formulation was developed which provided sustained release (SR) of a primary analgesic… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
2009
2009
We investigated several methods of taste masking in the preparation of orally disintegrating tablets (ODTs), using furosemide (FU… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
PH-302 ( 1) demonstrates potent inhibitory activity against the inducible form of nitric oxide synthase (iNOS). The primary… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
PH-302 inhibits the inducible form of nitric oxide synthase (iNOS) by coordinating with the heme of the monomeric form and… (More)
Is this relevant?
2001
2001
The tabletting characteristics of low crystallinity celluloses (LCPC)-LCPC-700, LCPC-2000, and LCPC-4000-prepared using agitation… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
1999
1999
This study evaluates the influence of moisture content on the packing performances of a new grade of microcrystalline cellulose… (More)
Is this relevant?